Exact Mass: 287.1593

Exact Mass Matches: 287.1593

Found 190 metabolites which its exact mass value is equals to given mass value 287.1593, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Galantamine

(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol

C17H21NO3 (287.1521)


Galanthamine is a benzazepine alkaloid isolated from certain species of daffodils. It has a role as an antidote to curare poisoning, an EC 3.1.1.7 (acetylcholinesterase) inhibitor, a cholinergic drug, an EC 3.1.1.8 (cholinesterase) inhibitor and a plant metabolite. It is an organic heterotetracyclic compound, a tertiary amino compound, a benzazepine alkaloid and a benzazepine alkaloid fundamental parent. It is a conjugate base of a galanthamine(1+). Galantamine is a tertiary alkaloid and reversible, competitive inhibitor of the acetylcholinesterase (AChE) enzyme, which is a widely studied therapeutic target used in the treatment of Alzheimers disease. First characterized in the early 1950s, galantamine is a tertiary alkaloid that was extracted from botanical sources, such as Galanthus nivalis. Galantamine was first studied in paralytic and neuropathic conditions, such as myopathies and postpolio paralytic conditions, and for reversal of neuromuscular blockade. Following the discovery of its AChE-inhibiting properties, the cognitive effects of galantamine were studied in a wide variety of psychiatric disorders such as mild cognitive impairment, cognitive impairment in schizophrenia and bipolar disorder, and autism; however, re-development of the drug for Alzheimer’s disease did not commence until the early 1990s due to difficulties in extraction and synthesis. Galantamine blocks the breakdown of acetylcholine in the synaptic cleft, thereby increasing acetylcholine neurotransmission. It also acts as an allosteric modulator of the nicotinic receptor, giving its dual mechanism of action clinical significance. The drug was approved by the FDA in 2001 for the treatment of mild to moderate dementia of the Alzheimers type. As Alzheimers disease is a progressive neurodegenerative disorder, galantamine is not known to alter the course of the underlying dementing process. Galantamine works to block the enzyme responsible for the breakdown of acetylcholine in the synaptic cleft, thereby enhancing cholinergic neuron function and signalling. Under this hypothesized mechanism of action, the therapeutic effects of galantamine may decrease as the disease progression advances and fewer cholinergic neurons remain functionally intact. It is therefore not considered to be a disease-modifying drug. Galantamine is marketed under the brand name Razadyne, and is available as oral immediate- and extended-release tablets and solution. Galantamine is a Cholinesterase Inhibitor. The mechanism of action of galantamine is as a Cholinesterase Inhibitor. Galantamine is an oral acetylcholinesterase inhibitor used for therapy of Alzheimer disease. Galantamine is associated with a minimal rate of serum enzyme elevations during therapy and has not been implicated as a cause of clinically apparent liver injury. Galantamine is a natural product found in Pancratium trianthum, Lycoris sanguinea, and other organisms with data available. A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders. See also: Galantamine Hydrobromide (active moiety of). A benzazepine derived from norbelladine. It is found in galanthus and other amaryllidaceae. Galantamine is a cholinesterase inhibitor that has been used to reverse the muscular effects of gallamine triethiodide and tubocurarine, and has been studied as a treatment for Alzheimers disease and other central nervous system disorders. [PubChem] D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors N - Nervous system > N06 - Psychoanaleptics > N06D - Anti-dementia drugs > N06DA - Anticholinesterases D002491 - Central Nervous System Agents > D018697 - Nootropic Agents A benzazepine alkaloid isolated from certain species of daffodils. C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D004791 - Enzyme Inhibitors Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM. Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM.

   

Mesembrenone

6H-Indol-6-one, 3a-(3,4-dimethoxyphenyl)-1,2,3,3a,7,7a-hexahydro-1-methyl-, (3aR-cis)-

C17H21NO3 (287.1521)


Mesembrenone is a member of pyrrolidines. Mesembrenone is a natural product found in Bergeranthus scapiger, Oscularia deltoides, and other organisms with data available.

   

Etodolac

(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid

C17H21NO3 (287.1521)


Etodolac is only found in individuals that have used or taken this drug. It is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. Its therapeutic effects are due to its ability to inhibit prostaglandin synthesis. It is indicated for relief of signs and symptoms of rheumatoid arthritis and osteoarthritis. Similar to other NSAIDs, the anti-inflammatory effects of etodolac result from inhibition of the enzyme cycooxygenase (COX). This decreases the synthesis of peripheral prostaglandins involved in mediating inflammation. Etodolac binds to the upper portion of the COX enzyme active site and prevents its substrate, arachidonic acid, from entering the active site. Etodolac was previously thought to be a non-selective COX inhibitor, but it is now known to be 5 – 50 times more selective for COX-2 than COX-1. Antipyresis may occur by central action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat loss. M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents KEIO_ID E034; [MS2] KO008956 KEIO_ID E034

   

Cyproheptadine

1-methyl-4-{tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-ylidene}piperidine

C21H21N (287.1674)


Cyproheptadine is only found in individuals that have used or taken this drug. It is a serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc. [PubChem]Cyproheptadine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. Cyproheptadine also competes with serotonin at receptor sites in smooth muscle in the intestines and other locations. Antagonism of serotonin on the appetite center of the hypothalamus may account for Cyproheptadines ability to stimulate appetite. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D003879 - Dermatologic Agents > D000982 - Antipruritics D005765 - Gastrointestinal Agents D018926 - Anti-Allergic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Cyproheptadine is a potent and orally active 5-HT2A receptor antagonist, with antidepressant and antiserotonergic effects. Cyproheptadine has antiplatelet and thromboprotective activities. Cyproheptadine can be used for the research of thromboembolic disorders[1][2].

   

Dihydromorphine

(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,14-diol

C17H21NO3 (287.1521)


Dihydromorphine is a metabolite of Hydromorphone. Dihydromorphine is a semi-synthetic opioid structurally related to and derived from morphine. The 7,8-double bond in morphine is reduced to a single bond to get dihydromorphine. (Wikipedia) D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Naftifine

N-methyl-N-(1-naphthalenylmethyl)-3-phenyl-2-propen-1-amine

C21H21N (287.1674)


Naftifine is only found in individuals that have used or taken this drug. It is a synthetic, broad spectrum, antifungal agent and allylamine derivative for the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans and Epidermophyton floccosum.Although the exact mechanism of action against fungi is not known, naftifine appears to interfere with sterol biosynthesis by inhibiting the enzyme squalene 2,3-epoxidase. This inhibition of enzyme activity results in decreased amounts of sterols, especially ergosterol, and a corresponding accumulation of squalene in the cells. D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Ritodrine

4-(2-{[(1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)phenol

C17H21NO3 (287.1521)


Ritodrine is only found in individuals that have used or taken this drug. It is an adrenergic beta-agonist used to control premature labor. [PubChem]Ritodrine is beta-2 adrenergic agonist. It binds to beta-2 adrenergic receptors on outer membrane of myometrial cell, activates adenyl cyclase to increase the level of cAMP which decreases intracellular calcium and leads to a decrease of uterine contractions. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

   

Zolmitriptan

(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one

C16H21N3O2 (287.1634)


Zolmitriptan is only found in individuals that have used or taken this drug. It is a synthetic tryptamine derivative and appears as a white powder that is readily soluble in water. [Wikipedia]Zolmitriptan binds with high affinity to human 5-HT1B and 5-HT1D receptors leading to cranial blood vessel constriction. Current theories proposed to explain the etiology of migraine headache suggest that symptoms are due to local cranial vasodilatation and/or to the release of sensory neuropeptides (vasoactive intestinal peptide, substance P and calcitonin gene-related peptide) through nerve endings in the trigeminal system. The therapeutic activity of zolmitriptan for the treatment of migraine headache can most likely be attributed to the agonist effects at the 5HT1B/1D receptors on intracranial blood vessels (including the arterio-venous anastomoses) and sensory nerves of the trigeminal system which result in cranial vessel constriction and inhibition of pro-inflammatory neuropeptide release. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D000890 - Anti-Infective Agents > D023303 - Oxazolidinones

   
   

Piperanine

(2E)-5-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)pent-2-en-1-one

C17H21NO3 (287.1521)


Isolated from pepper. Piperanine is found in herbs and spices and pepper (spice). Piperanine is found in herbs and spices. Piperanine is isolated from pepper.

   

Feruperine

(2E,4Z)-5-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

C17H21NO3 (287.1521)


Alkaloid from pepper (Piper nigrum) (Piperaceae). Feruperine is found in herbs and spices and pepper (spice). Feruperine is found in herbs and spices. Feruperine is an alkaloid from pepper (Piper nigrum) (Piperaceae).

   

Arginylhydroxyproline

(2S,4R)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]-4-hydroxypyrrolidine-2-carboxylic acid

C11H21N5O4 (287.1593)


Arginylhydroxyproline is a dipeptide composed of arginine and hydroxyproline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Hydroxyprolyl-Arginine

5-Carbamimidamido-2-{[hydroxy(4-hydroxypyrrolidin-2-yl)methylidene]amino}pentanoate

C11H21N5O4 (287.1593)


Hydroxyprolyl-Arginine is a dipeptide composed of hydroxyproline and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Nordihydrocodeine

(1S,5R,14S)-10-methoxy-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-trien-14-ol

C17H21NO3 (287.1521)


Nordihydrocodeine belongs to the family of Morphinans. These are polycyclic compounds with a four-ring skeleton with three condensed six-member rings forming a partially hydrogenated phenanthrene moiety, one of which is aromatic while the two others are alicyclic.

   

6alpha-Hydroxy-hydromorphone

(14S)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-triene-10,14-diol

C17H21NO3 (287.1521)


6alpha-Hydroxy-hydromorphone is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)

   

6beta-Hydroxy-hydromorphone

(14R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-triene-10,14-diol

C17H21NO3 (287.1521)


6beta-Hydroxy-hydromorphone is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)

   

Dihydroisomorphine

(1S,5R,13R,14R,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18)-triene-10,14-diol

C17H21NO3 (287.1521)


Dihydroisomorphine is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)

   

(4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one

4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one

C16H21N3O2 (287.1634)


   

Ritodrina

4-(1-hydroxy-2-{[2-(4-hydroxyphenyl)ethyl]amino}propyl)phenol

C17H21NO3 (287.1521)


G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

   

Cyanopindolol

4-[3-(tert-butylamino)-2-hydroxypropoxy]-1H-indole-2-carbonitrile

C16H21N3O2 (287.1634)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

Hydromorphine

4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,14-diol

C17H21NO3 (287.1521)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Epigalanthamin

9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-ol

C17H21NO3 (287.1521)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D004791 - Enzyme Inhibitors

   

Tribenzylamine

Tribenzylamine

C21H21N (287.1674)


   

Thesinine

(Hexahydro-1H-pyrrolizin-1-yl)methyl (2E)-3-(4-hydroxyphenyl)prop-2-enoic acid

C17H21NO3 (287.1521)


Thesinine is a member of the class of compounds known as coumaric acid esters. Coumaric acid esters are aromatic compounds containing an ester derivative of coumaric acid. Thesinine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Thesinine can be found in borage, which makes thesinine a potential biomarker for the consumption of this food product. Thesinine is a pyrrolizidine alkaloid first isolated from Thesium minkwitzianum from which it derives its name. It is also found in the flowers and seeds of borage .

   

(-)-N-(2-Oxopyrrolidinomethyl)cytisine

(-)-N-(2-Oxopyrrolidinomethyl)cytisine

C16H21N3O2 (287.1634)


   

SCHEMBL19532552

SCHEMBL19532552

C17H21NO3 (287.1521)


   

Solanapyrone G

Solanapyrone G

C17H21NO3 (287.1521)


   

O-Methylglycosolone

4,8-Dimethoxy-1-methyl-3-prenylquinolin-2-one

C17H21NO3 (287.1521)


   

Cocculitinine

Cocculitinine

C17H21NO3 (287.1521)


   

Latisodine

4-[2-[(3,4-dimethoxyphenyl)methylamino]ethyl]phenol

C17H21NO3 (287.1521)


   

Pluviine

O-Methylnorpluviine

C17H21NO3 (287.1521)


   

Homoglycosolone

Homoglycosolone

C17H21NO3 (287.1521)


   

Malatyamine ethylester

Malatyamine ethylester

C17H21NO3 (287.1521)


   

D7-Mesembrenone

D7-Mesembrenone

C17H21NO3 (287.1521)


   

SCHEMBL18924768

SCHEMBL18924768

C17H21NO3 (287.1521)


   

Tribenzylamine

Tribenzylamine

C21H21N (287.1674)


CONFIDENCE standard compound; INTERNAL_ID 1132; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8039; ORIGINAL_PRECURSOR_SCAN_NO 8037 CONFIDENCE standard compound; INTERNAL_ID 1132; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8040; ORIGINAL_PRECURSOR_SCAN_NO 8038 CONFIDENCE standard compound; INTERNAL_ID 1132; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8054; ORIGINAL_PRECURSOR_SCAN_NO 8052 CONFIDENCE standard compound; INTERNAL_ID 1132; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8082; ORIGINAL_PRECURSOR_SCAN_NO 8080 CONFIDENCE standard compound; INTERNAL_ID 1132; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8101; ORIGINAL_PRECURSOR_SCAN_NO 8100 CONFIDENCE standard compound; INTERNAL_ID 1132; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8147; ORIGINAL_PRECURSOR_SCAN_NO 8146 CONFIDENCE standard compound; INTERNAL_ID 8376

   

10-Epilitsericine

10-Epilitsericine

C17H21NO3 (287.1521)


   
   

(-)-8-norindolactam V|(-)-des-N-methylindolactam-V|(-)-N13-desmethylindolactam V|(-)-N13-desmethylindolactam-V|des-methyl-(-)-indolactam V|des-N-methylindolactam V|desmethyl indolactam V

(-)-8-norindolactam V|(-)-des-N-methylindolactam-V|(-)-N13-desmethylindolactam V|(-)-N13-desmethylindolactam-V|des-methyl-(-)-indolactam V|des-N-methylindolactam V|desmethyl indolactam V

C16H21N3O2 (287.1634)


   
   

Benzoylecgonine

Benzoylecgonine

C17H21NO3 (287.1521)


   
   

5t-benzo[1,3]dioxol-5-yl-penta-2t,4-dienoic acid isopentylamide|5t-Benzo[1,3]dioxol-5-yl-penta-2t,4-diensaeure-isopentylamid|piperic acid isopentyl amide

5t-benzo[1,3]dioxol-5-yl-penta-2t,4-dienoic acid isopentylamide|5t-Benzo[1,3]dioxol-5-yl-penta-2t,4-diensaeure-isopentylamid|piperic acid isopentyl amide

C17H21NO3 (287.1521)


   

l-Rotundin, l-Tetrahydropalmatine|Rotundin

l-Rotundin, l-Tetrahydropalmatine|Rotundin

C17H21NO3 (287.1521)


   

3-O-methylepimacowine

3-O-methylepimacowine

C17H21NO3 (287.1521)


   

bisdehydroneostemoninine

bisdehydroneostemoninine

C17H21NO3 (287.1521)


   

7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienoic acid

7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxohepta-2,4-dienoic acid

C17H21NO3 (287.1521)


   

3alpha-cynnamoyloxytropan-6beta-ol

3alpha-cynnamoyloxytropan-6beta-ol

C17H21NO3 (287.1521)


   
   

4-(2-(3,4-Dimethoxybenzylamino)ethyl)phenol

4-(2-(3,4-Dimethoxybenzylamino)ethyl)phenol

C17H21NO3 (287.1521)


   
   

Epigalantamine

(1S,12S,14S)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0?,??.0?,??]heptadeca-6(17),7,9,15-tetraen-14-ol

C17H21NO3 (287.1521)


Epigalantamine is a natural product found in Lycoris sanguinea, Lycoris radiata, and other organisms with data available.

   

etodolac

etodolac

C17H21NO3 (287.1521)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3308

   

naftifine

naftifine

C21H21N (287.1674)


D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 3581

   

Galantamine

(-)Galanthamine

C17H21NO3 (287.1521)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors N - Nervous system > N06 - Psychoanaleptics > N06D - Anti-dementia drugs > N06DA - Anticholinesterases Origin: Plant; SubCategory_DNP: Isoquinoline alkaloids, Amaryllidaceae alkaloids D002491 - Central Nervous System Agents > D018697 - Nootropic Agents C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D004791 - Enzyme Inhibitors Origin: Plant, Benzazepines CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 27 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.263 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.257 Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM. Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM.

   

Etodolac (Lodine)

Etodolac (Lodine)

C17H21NO3 (287.1521)


   

Zolmitriptan

Zolmitriptan (Zomig)

C16H21N3O2 (287.1634)


N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D000890 - Anti-Infective Agents > D023303 - Oxazolidinones

   

(E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpent-2-en-1-one

NCGC00180838-02!(E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpent-2-en-1-one

C17H21NO3 (287.1521)


   

C17H21NO3_3a-(3,4-Dimethoxyphenyl)-1-methyl-1,2,3,3a,4,5-hexahydro-6H-indol-6-one

NCGC00385278-01_C17H21NO3_3a-(3,4-Dimethoxyphenyl)-1-methyl-1,2,3,3a,4,5-hexahydro-6H-indol-6-one

C17H21NO3 (287.1521)


   

CYPROHEPTADINE

CYPROHEPTADINE

C21H21N (287.1674)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D003879 - Dermatologic Agents > D000982 - Antipruritics D005765 - Gastrointestinal Agents D018926 - Anti-Allergic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Cyproheptadine is a potent and orally active 5-HT2A receptor antagonist, with antidepressant and antiserotonergic effects. Cyproheptadine has antiplatelet and thromboprotective activities. Cyproheptadine can be used for the research of thromboembolic disorders[1][2].

   
   

Piperanine

(2E)-5-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)pent-2-en-1-one

C17H21NO3 (287.1521)


   

3a-(3,4-dimethoxyphenyl)-1-methyl-2,3,4,5-tetrahydroindol-6-one

3a-(3,4-dimethoxyphenyl)-1-methyl-2,3,4,5-tetrahydroindol-6-one

C17H21NO3 (287.1521)


   

4-O,N-dimethylnorbelladine

4-O,N-dimethylnorbelladine

C17H21NO3 (287.1521)


   

heptyltyrazolone

heptyltyrazolone

C17H21NO3 (287.1521)


   

Piperanine_major

Piperanine_major

C17H21NO3 (287.1521)


   

GALANTHAMINE_77.1\\%

GALANTHAMINE_77.1\\%

C17H21NO3 (287.1521)


   

GALANTHAMINE_major

GALANTHAMINE_major

C17H21NO3 (287.1521)


   

GALANTHAMINE_53.1\\%

GALANTHAMINE_53.1\\%

C17H21NO3 (287.1521)


   

Nordihydrocodeine

(9-methoxy-3-trimethylsilyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl)oxy-trimethylsilane

C17H21NO3 (287.1521)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids

   

Arg-hpro

5-carbamimidamido-2-[(4-hydroxypyrrolidin-2-yl)formamido]pentanoic acid

C11H21N5O4 (287.1593)


   

Hpro-arg

1-(2-amino-5-carbamimidamidopentanoyl)-4-hydroxypyrrolidine-2-carboxylic acid

C11H21N5O4 (287.1593)


   

Feruperine

(2E,4Z)-5-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

C17H21NO3 (287.1521)


   

tert-butyl 4-(4-cyanophenyl)piperazine-1-carboxylate

tert-butyl 4-(4-cyanophenyl)piperazine-1-carboxylate

C16H21N3O2 (287.1634)


   

4-tert-butyl-2-[3-(trifluoromethyl)phenyl]morpholine

4-tert-butyl-2-[3-(trifluoromethyl)phenyl]morpholine

C15H20F3NO (287.1497)


   

N-(2,4-Dimthylphenyl)-N-p-tolylbenzenamine

N-(2,4-Dimthylphenyl)-N-p-tolylbenzenamine

C21H21N (287.1674)


   

2-(2-METHYL-2H-TETRAZOL-5-YL)-5-(4,4,5,5-TETRAMETHYL-1,3, - 2DIOXABOROLAN-2-YL)PYRIDINE

2-(2-METHYL-2H-TETRAZOL-5-YL)-5-(4,4,5,5-TETRAMETHYL-1,3, - 2DIOXABOROLAN-2-YL)PYRIDINE

C13H18BN5O2 (287.1553)


   

2,6-dimethoxy-4-[(1-phenylethylamino)methyl]phenol

2,6-dimethoxy-4-[(1-phenylethylamino)methyl]phenol

C17H21NO3 (287.1521)


   

tert-butyl 7-ethoxynaphthalen-1-ylcarbamate

tert-butyl 7-ethoxynaphthalen-1-ylcarbamate

C17H21NO3 (287.1521)


   

BENZYL-(3,4,5-TRIMETHOXYBENZYL)AMINE

BENZYL-(3,4,5-TRIMETHOXYBENZYL)AMINE

C17H21NO3 (287.1521)


   

(3S,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]azetidin-2-one

(3S,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]azetidin-2-one

C13H25NO4Si (287.1553)


   

3-Amino-1-(2-ethoxyphenoxy)-1-phenyl-2-propanol

3-Amino-1-(2-ethoxyphenoxy)-1-phenyl-2-propanol

C17H21NO3 (287.1521)


   

(2-Ethyl-6-methylphenyl)diphenylamine

(2-Ethyl-6-methylphenyl)diphenylamine

C21H21N (287.1674)


   

(2R,3R)-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methyl-3-pentanol hydrochloride

(2R,3R)-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methyl-3-pentanol hydrochloride

C15H26ClNO2 (287.1652)


   

Zolmitriptan R-Isomer

Zolmitriptan R-Isomer

C16H21N3O2 (287.1634)


   

N-Cyclopropyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

N-Cyclopropyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C16H22BNO3 (287.1693)


   

(S)-(-)-1,1-DIPHENYL-1,2-PROPANEDIOL

(S)-(-)-1,1-DIPHENYL-1,2-PROPANEDIOL

C21H21N (287.1674)


   

BENZYL-(1-BIPHENYL-4-YL-ETHYL)AMINE

BENZYL-(1-BIPHENYL-4-YL-ETHYL)AMINE

C21H21N (287.1674)


   

(R)-(+)-1,2-EPOXYTETRADECANE

(R)-(+)-1,2-EPOXYTETRADECANE

C21H21N (287.1674)


   

4-((4-ethylpiperazin-1-yl)Methyl)-3-(trifluoromethyl)aniline

4-((4-ethylpiperazin-1-yl)Methyl)-3-(trifluoromethyl)aniline

C14H20F3N3 (287.1609)


   

N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C16H22BNO3 (287.1693)


   

N-formylpropranolol

N-formylpropranolol

C17H21NO3 (287.1521)


   

1,1-DIMETHYLETHYL [2-HYDROXY-2-(1-NAPHTHALENYL)ETHYL]CARBAMATE

1,1-DIMETHYLETHYL [2-HYDROXY-2-(1-NAPHTHALENYL)ETHYL]CARBAMATE

C17H21NO3 (287.1521)


   

(2S,3R)-1-(dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol (hydrochloride)

(2S,3R)-1-(dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol (hydrochloride)

C15H26ClNO2 (287.1652)


   

2-(2,6-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile

2-(2,6-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile

C16H22BNO3 (287.1693)


   

5-Methoxy-1-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

5-Methoxy-1-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

C16H22BNO3 (287.1693)


   

tert-butyl 4-(2-cyanophenyl)piperazine-1-carboxylate

tert-butyl 4-(2-cyanophenyl)piperazine-1-carboxylate

C16H21N3O2 (287.1634)


   

1,3-Diazaspiro[4.5]decane-2,4-dione,8-methyl-3-[(phenylamino)methyl]-

1,3-Diazaspiro[4.5]decane-2,4-dione,8-methyl-3-[(phenylamino)methyl]-

C16H21N3O2 (287.1634)


   

4,4,4-Trimethyltriphenylamine

4,4,4-Trimethyltriphenylamine

C21H21N (287.1674)


   

Numidargistat

Numidargistat

C11H22BN3O5 (287.1652)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C308 - Immunotherapeutic Agent D004791 - Enzyme Inhibitors

   

2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-

2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-

C16H21N3O2 (287.1634)


   
   
   

(R)-trichostatic acid

(R)-trichostatic acid

C17H21NO3 (287.1521)


   

Trichostatic acid

Trichostatic acid

C17H21NO3 (287.1521)


   

(S)-trichostatic acid

(S)-trichostatic acid

C17H21NO3 (287.1521)


   

3-[3-(4-tert-butylphenyl)-1,2,4-oxadiazol-5-yl]-N-methylpropanamide

3-[3-(4-tert-butylphenyl)-1,2,4-oxadiazol-5-yl]-N-methylpropanamide

C16H21N3O2 (287.1634)


   

3,4-Dibenzyl-2,5-dimethylpyridine

3,4-Dibenzyl-2,5-dimethylpyridine

C21H21N (287.1674)


   

4-{[(2s)-3-(Tert-Butylamino)-2-Hydroxypropyl]oxy}-3h-Indole-2-Carbonitrile

4-{[(2s)-3-(Tert-Butylamino)-2-Hydroxypropyl]oxy}-3h-Indole-2-Carbonitrile

C16H21N3O2 (287.1634)


   

(1S)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol

(1S)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol

C17H21NO3 (287.1521)


   

3-oxononanoyl-N-acetylcysteamine

3-oxononanoyl-N-acetylcysteamine

C14H25NO3S (287.1555)


   

[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-oxo-2-phenylpropanoate

[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-oxo-2-phenylpropanoate

C17H21NO3 (287.1521)


   

Nordihydroisomorphine

Nordihydroisomorphine

C17H21NO3 (287.1521)


   

Arginylhydroxyproline

Arginylhydroxyproline

C11H21N5O4 (287.1593)


   

2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-ylmethyl (E)-3-(4-hydroxyphenyl)prop-2-enoate

2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-ylmethyl (E)-3-(4-hydroxyphenyl)prop-2-enoate

C17H21NO3 (287.1521)


   

Yutopar

4-[2-[[(1S,2R)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol

C17H21NO3 (287.1521)


G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

   

4-[(Bicyclo[4.1.0]heptane-7-carbonyl)-amino]-benzoic acid ethyl ester

4-[(Bicyclo[4.1.0]heptane-7-carbonyl)-amino]-benzoic acid ethyl ester

C17H21NO3 (287.1521)


   

(2E)-3-azepan-1-yl-2-[(3-fluorophenyl)hydrazono]-3-iminopropanenitrile

(2E)-3-azepan-1-yl-2-[(3-fluorophenyl)hydrazono]-3-iminopropanenitrile

C15H18FN5 (287.1546)


   

4-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-1H-indole-2-carbonitrile

4-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-1H-indole-2-carbonitrile

C16H21N3O2 (287.1634)


   

1-[(3-hydroxy-4-methoxyphenyl)methyl]-2,3,4,7,8,8a-hexahydro-1H-isoquinolin-6-one

1-[(3-hydroxy-4-methoxyphenyl)methyl]-2,3,4,7,8,8a-hexahydro-1H-isoquinolin-6-one

C17H21NO3 (287.1521)


   

3-[5-(4-Methoxyphenyl)-1-propyl-2-pyrrolyl]propanoic acid

3-[5-(4-Methoxyphenyl)-1-propyl-2-pyrrolyl]propanoic acid

C17H21NO3 (287.1521)


   

N-[(2S)-3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propionamide

N-[(2S)-3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propionamide

C17H21NO3 (287.1521)


   

N-[(2R)-3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propionamide

N-[(2R)-3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propionamide

C17H21NO3 (287.1521)


   

N-[3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propionamide

N-[3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propionamide

C17H21NO3 (287.1521)


   

(4aR,7aR)-9-methoxy-3-methyl-2,4,4a,5,6,7a-hexahydro-1H-benzofuro[3,2-e]isoquinolin-7-one

(4aR,7aR)-9-methoxy-3-methyl-2,4,4a,5,6,7a-hexahydro-1H-benzofuro[3,2-e]isoquinolin-7-one

C17H21NO3 (287.1521)


   

Arginyl-4-hydroxyproline

Arginyl-4-hydroxyproline

C11H21N5O4 (287.1593)


   

N-ethyl-3-[3-(4-propan-2-ylphenyl)-1,2,4-oxadiazol-5-yl]propanamide

N-ethyl-3-[3-(4-propan-2-ylphenyl)-1,2,4-oxadiazol-5-yl]propanamide

C16H21N3O2 (287.1634)


   

N-[(E)-1-(4-acetamidophenyl)ethylideneamino]cyclopentanecarboxamide

N-[(E)-1-(4-acetamidophenyl)ethylideneamino]cyclopentanecarboxamide

C16H21N3O2 (287.1634)


   

(3R,8Z,11R)-11-methyl-3-phenyl-1-oxa-5-azacyclododec-8-ene-4,12-dione

(3R,8Z,11R)-11-methyl-3-phenyl-1-oxa-5-azacyclododec-8-ene-4,12-dione

C17H21NO3 (287.1521)


   

ethyl 2-[(1S)-8-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetate

ethyl 2-[(1S)-8-ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetate

C17H21NO3 (287.1521)


   

(4S,9Z,12R)-12-methyl-4-phenyl-1-oxa-5-azacyclododec-9-ene-2,6-dione

(4S,9Z,12R)-12-methyl-4-phenyl-1-oxa-5-azacyclododec-9-ene-2,6-dione

C17H21NO3 (287.1521)


   

(2E)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]oct-2-enoate

(2E)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]oct-2-enoate

C14H23O6- (287.1495)


   

2-(1,8-diethyl-4,8-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid

2-(1,8-diethyl-4,8-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid

C17H21NO3 (287.1521)


   

2-[(4-Methoxyphenyl)methyliminomethyl]-5,5-dimethylcyclohexane-1,3-dione

2-[(4-Methoxyphenyl)methyliminomethyl]-5,5-dimethylcyclohexane-1,3-dione

C17H21NO3 (287.1521)


   

(E,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyoct-2-enoate

(E,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyoct-2-enoate

C14H23O6- (287.1495)


   

[4-Methyl-1-(1-methylindol-3-yl)-3-oxopentan-2-yl] acetate

[4-Methyl-1-(1-methylindol-3-yl)-3-oxopentan-2-yl] acetate

C17H21NO3 (287.1521)


   

[(2S,4S)-1-(1H-indol-3-yl)-4-methyl-3-oxohexan-2-yl] acetate

[(2S,4S)-1-(1H-indol-3-yl)-4-methyl-3-oxohexan-2-yl] acetate

C17H21NO3 (287.1521)


   

[(2S)-1-(1H-indol-3-yl)-4-methyl-3-oxopentan-2-yl] propanoate

[(2S)-1-(1H-indol-3-yl)-4-methyl-3-oxopentan-2-yl] propanoate

C17H21NO3 (287.1521)


   

2,4-Dibenzyl-3,6-dimethylpyridine

2,4-Dibenzyl-3,6-dimethylpyridine

C21H21N (287.1674)


   

ritodrine

ritodrine

C17H21NO3 (287.1521)


G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

   

Dihydromorphine

Dihydromorphine

C17H21NO3 (287.1521)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Epigalanthamin

Epigalanthamin

C17H21NO3 (287.1521)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D004791 - Enzyme Inhibitors

   

Ritodrina

Ritodrine hydrochloride

C17H21NO3 (287.1521)


G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

   

Cyanopindolol

Cyanopindolol

C16H21N3O2 (287.1634)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

Hydroxyprolyl-Arginine

Hydroxyprolyl-Arginine

C11H21N5O4 (287.1593)


   

6alpha-Hydroxy-hydromorphone

6alpha-Hydroxy-hydromorphone

C17H21NO3 (287.1521)


   

Arginyl-hydroxyproline

Arginyl-hydroxyproline

C11H21N5O4 (287.1593)


   

ascr#13(1-)

ascr#13(1-)

C14H23O6 (287.1495)


Conjugate base of ascr#13

   
   

oscr#13(1-)

oscr#13(1-)

C14H23O6 (287.1495)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#13, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

O-Desmethyl Mebeverine alcohol (hydrochloride)

O-Desmethyl Mebeverine alcohol (hydrochloride)

C15H26ClNO2 (287.1652)


O-Desmethyl Mebeverine alcohol hydrochloride is a metabolite of Mebeverine, which is a potent α1 repector inhibitor, causing relaxation of the gastrointestinal tract.

   

1-(1h-indol-3-yl)-4-methyl-3-oxohexan-2-yl acetate

1-(1h-indol-3-yl)-4-methyl-3-oxohexan-2-yl acetate

C17H21NO3 (287.1521)


   

11-[(2-oxopyrrolidin-1-yl)methyl]-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

11-[(2-oxopyrrolidin-1-yl)methyl]-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C16H21N3O2 (287.1634)


   

5-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

5-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

C17H21NO3 (287.1521)


   

(1r,5r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-phenylprop-2-enoate

(1r,5r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-phenylprop-2-enoate

C17H21NO3 (287.1521)


   

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylprop-2-enoate

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylprop-2-enoate

C17H21NO3 (287.1521)


   

(9bs,11r,12r)-11-methoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline-8,12-diol

(9bs,11r,12r)-11-methoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline-8,12-diol

C17H21NO3 (287.1521)


   

2-epigalanthamine

NA

C17H21NO3 (287.1521)


{"Ingredient_id": "HBIN005583","Ingredient_name": "2-epigalanthamine","Alias": "NA","Ingredient_formula": "C17H21NO3","Ingredient_Smile": "CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6919","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-phenylprop-2-enoate

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-phenylprop-2-enoate

C17H21NO3 (287.1521)


   

4,8-dimethoxy-1-methyl-3-(3-methylbut-2-en-1-yl)quinolin-2-one

4,8-dimethoxy-1-methyl-3-(3-methylbut-2-en-1-yl)quinolin-2-one

C17H21NO3 (287.1521)


   

3a-(3,4-dimethoxyphenyl)-1-methyl-2,3,7,7a-tetrahydroindol-6-one

3a-(3,4-dimethoxyphenyl)-1-methyl-2,3,7,7a-tetrahydroindol-6-one

C17H21NO3 (287.1521)


   

(2r)-1-(1h-indol-3-yl)-4-methyl-3-oxohexan-2-yl acetate

(2r)-1-(1h-indol-3-yl)-4-methyl-3-oxohexan-2-yl acetate

C17H21NO3 (287.1521)


   

(1r,9s)-11-[(2-oxopyrrolidin-1-yl)methyl]-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

(1r,9s)-11-[(2-oxopyrrolidin-1-yl)methyl]-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C16H21N3O2 (287.1634)


   

6-[(1r,2s,4ar,8ar)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-4-amino-2-oxopyran-3-carbaldehyde

6-[(1r,2s,4ar,8ar)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-4-amino-2-oxopyran-3-carbaldehyde

C17H21NO3 (287.1521)


   

(1s,12s,14r)-14-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-9-ol

(1s,12s,14r)-14-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-9-ol

C17H21NO3 (287.1521)


   

5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylbutyl)penta-2,4-dienamide

5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylbutyl)penta-2,4-dienamide

C17H21NO3 (287.1521)


   

(3as)-3a-(3,4-dimethoxyphenyl)-1-methyl-2,3,7,7a-tetrahydroindol-6-one

(3as)-3a-(3,4-dimethoxyphenyl)-1-methyl-2,3,7,7a-tetrahydroindol-6-one

C17H21NO3 (287.1521)


   

9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 2-phenylpropanoate

9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 2-phenylpropanoate

C17H21NO3 (287.1521)


   

(10s,13s)-13-(hydroxymethyl)-10-isopropyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

(10s,13s)-13-(hydroxymethyl)-10-isopropyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

C16H21N3O2 (287.1634)


   

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-phenylprop-2-enoate

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-phenylprop-2-enoate

C17H21NO3 (287.1521)


   

(1r,10s,12r)-4,5-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraen-12-ol

(1r,10s,12r)-4,5-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraen-12-ol

C17H21NO3 (287.1521)


   

(1r,10s,12s)-4,5-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraen-12-ol

(1r,10s,12s)-4,5-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraen-12-ol

C17H21NO3 (287.1521)


   

(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-(3-methylbutyl)penta-2,4-dienimidic acid

(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-(3-methylbutyl)penta-2,4-dienimidic acid

C17H21NO3 (287.1521)


   

13-(hydroxymethyl)-10-isopropyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

13-(hydroxymethyl)-10-isopropyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

C16H21N3O2 (287.1634)


   

14-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-9-ol

14-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-9-ol

C17H21NO3 (287.1521)


   

(+)-trichostatic acid

(+)-trichostatic acid

C17H21NO3 (287.1521)


   

(1s,15r,16s)-4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraen-15-ol

(1s,15r,16s)-4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraen-15-ol

C17H21NO3 (287.1521)


   

5-(2h-1,3-benzodioxol-5-yl)-n-(3-methylbutyl)penta-2,4-dienamide

5-(2h-1,3-benzodioxol-5-yl)-n-(3-methylbutyl)penta-2,4-dienamide

C17H21NO3 (287.1521)


   

(1s,4s,12'r)-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2'(6'),7'-trien-4-ol

(1s,4s,12'r)-3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2'(6'),7'-trien-4-ol

C17H21NO3 (287.1521)


   

(1s,15r)-4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraen-15-ol

(1s,15r)-4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraen-15-ol

C17H21NO3 (287.1521)


   

4-(2-{[(3,4-dimethoxyphenyl)methyl]amino}ethyl)phenol

4-(2-{[(3,4-dimethoxyphenyl)methyl]amino}ethyl)phenol

C17H21NO3 (287.1521)


   

5-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)pent-2-en-1-one

5-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)pent-2-en-1-one

C17H21NO3 (287.1521)


   

4,5-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraen-12-ol

4,5-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraen-12-ol

C17H21NO3 (287.1521)


   

3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2'(6'),7'-trien-4-ol

3',5'-dioxa-11'-azaspiro[cyclohexane-1,14'-tetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadecane]-1'(15'),2'(6'),7'-trien-4-ol

C17H21NO3 (287.1521)


   

15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene

15-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene

C17H21NO3 (287.1521)


   

(2e,4e)-5-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

(2e,4e)-5-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

C17H21NO3 (287.1521)


   

2-{[(2e,4e)-1-hydroxy-4-methylhexa-2,4-dien-1-ylidene]amino}-3-phenylbutanoic acid

2-{[(2e,4e)-1-hydroxy-4-methylhexa-2,4-dien-1-ylidene]amino}-3-phenylbutanoic acid

C17H21NO3 (287.1521)


   

(1r,12s)-5,12-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraen-4-ol

(1r,12s)-5,12-dimethoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraen-4-ol

C17H21NO3 (287.1521)


   

(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-[(2r)-2-methylbutyl]penta-2,4-dienimidic acid

(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-[(2r)-2-methylbutyl]penta-2,4-dienimidic acid

C17H21NO3 (287.1521)